# Progress Note 03 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Richard Roundtree (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML015-SYN
- Date: 2026-10-20
- Fictional facility: St. Posthumous Health Center
- Fictional author: Leon Carrington, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Review two weeks after left breast cancer surgery. **S**

## History of present illness

Mr. Roundtree returns thirteen days after mastectomy with level I and II axillary dissection for left breast cancer. He went home the next day. The drain was removed on the eighth day, and the wound has healed without infection or fluid. He took acetaminophen for the first ten days and needs nothing now. He has numbness under the left arm, as he was warned, and some tightness when he lifts the arm, which is improving with the exercises. He has no arm swelling. The pathology shows a 1.6 cm grade 3 invasive ductal carcinoma with clear margins, and 2 of 15 lymph nodes involved, the largest 7 mm, with no spread through the node capsule: stage IIA (pT1c pN1a). He saw medical oncology four days ago. They advised doxorubicin and cyclophosphamide every three weeks for four cycles, then weekly paclitaxel for twelve weeks, about six months in all, starting in about two weeks, then tamoxifen for at least five years, and a radiation oncology review after chemotherapy. An echocardiogram is booked this week. The germline result is not back. He feels low at times and worries about losing his hair and about work, but he is sleeping and eating. **S**

| Element | Detail |
|---|---|
| Surgery | Mastectomy and axillary dissection thirteen days ago; drain out; wound healed |
| Pathology | pT1c pN1a, grade 3, margins clear; stage IIA |
| Arm | Numbness under the arm; tightness improving; no swelling |
| Plan from oncology | About six months of chemotherapy, then tamoxifen; radiation oncology review afterwards |
| Mood | Low at times; PHQ-9 score 6 |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever; appetite good |
| Integumentary | Negative | Wound healed; no redness or discharge |
| Musculoskeletal | Positive | Tightness at the end of left shoulder movement |
| Neurological | Positive | Numbness under the left arm |
| Cardiovascular | Negative | No chest pain, palpitations, or breathlessness on exertion |
| Psychiatric | Positive | Low at times; PHQ-9 score 6; no thoughts of self-harm |

6 systems reviewed. **S**

## Current medications

- No current medications. **S**

## Allergies

- No known allergy **S**

## Objective

BP 126/78 mmHg; pulse 76 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 99% on room air; weight 84.8 kg; BMI 24 kg/m². All vital signs are synthetic.

Hemoglobin: 13.9 g/dL; White cell count: 7 10*3/uL; Absolute neutrophil count: 4.3 10*3/uL; Platelets: 281 10*3/uL; Creatinine: 0.98 mg/dL; eGFR: 93 mL/min/1.73 m²; ALT: 21 U/L; Total bilirubin: 0.6 mg/dL; Albumin: 4.3 g/dL; PHQ-9: 6. All results are synthetic.

## Physical examination

| System | Finding |
|---|---|
| General | Well |
| Chest wall | Left mastectomy scar healed; no seroma, redness, or nodule; drain site healed |
| Lymph nodes | Left axillary scar healed; no nodes on either side |
| Musculoskeletal | Left shoulder flexion 150 degrees and abduction 130 degrees |
| Neurological | Reduced light touch over the inner left upper arm and armpit; strength normal |
| Extremities | Upper arm circumference 33.5 cm on both sides, 15 cm below the shoulder tip; no swelling of the left hand or forearm |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Left breast cancer, pathologic stage IIA (pT1c pN1a), after mastectomy and axillary dissection** (C50.122). Healing well. Grade 3, node-positive, hormone receptor-positive disease in a man of 51, for which chemotherapy followed by tamoxifen is the standard plan. Blood count, kidney, and liver function allow full-dose chemotherapy. **S**
   - Echocardiogram this week before doxorubicin.
   - Preventive visit next week for vaccines and hepatitis B screening before chemotherapy; dental check before the first cycle.
   - Continue shoulder exercises; a physical therapy session if movement has not returned by the first cycle.
   - Sperm banking offered by oncology before chemotherapy; his decision is with them.
2. **Estrogen receptor-positive status** (Z17.0). Tamoxifen after chemotherapy for at least five years; an aromatase inhibitor alone is not used in men. **S**
   - Tamoxifen safety monitoring to start with treatment: clot symptoms, mood, hot flashes, sexual side effects, and adherence.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | Blood count before chemotherapy | Before cycle 1 and each cycle (oncology) | Completed today | Hemoglobin 13.9 g/dL, white cells 7.0, neutrophils 4.3, platelets 281 |
| Laboratory | Kidney and liver function before chemotherapy | Before cycle 1 (oncology) | Completed today | Creatinine 0.98 mg/dL, eGFR 93; ALT 21 U/L, bilirubin 0.6 mg/dL, albumin 4.3 g/dL |
| Imaging | Echocardiogram with ejection fraction before anthracycline | Baseline before doxorubicin | Ordered | Booked this week |
| Laboratory | Hepatitis B screening before chemotherapy | Before the first cycle | Due | To be drawn at the preventive visit next week |
| Laboratory | Germline multigene panel testing | Once, for every man with breast cancer | Ordered | Sent fifteen days ago; result not yet back |
| Examination | Wound and shoulder movement after axillary surgery | Each visit after surgery | Completed today | Healed; flexion 150 degrees, improving |
| Examination | Lymphedema assessment and risk-reduction counseling | Every visit after axillary surgery | Completed today | Upper arm circumference 33.5 cm on both sides; skin care, avoiding tight sleeves on the left arm, and early reporting of swelling taught |
| Examination | Baseline arm circumference missed before surgery | Once, before axillary surgery | Deferred | Not measured before the operation, a deviation from the protocol. Measured today at thirteen days, before any swelling, and equal on both sides; the right arm serves as the reference. No harm is evident, and future measurements will be compared with today's |
| Survey | Distress and depression screen (PHQ-9) | Each visit | Completed today | PHQ-9 score 6, mild; no thoughts of self-harm; peer support and counseling offered |
| Medication safety | Tamoxifen safety (clot symptoms, mood, hot flashes, sexual side effects, adherence) | Every visit once tamoxifen starts | Not indicated | Tamoxifen starts after chemotherapy |
| Imaging | Mammography | Yearly only for a breast treated by lumpectomy, or the other breast with a predisposing variant | Not indicated | No breast was treated by lumpectomy. Imaging of the other side is considered only with a predisposing variant, and the germline result is pending |
| Self-management | Physical activity | Every visit | Completed today | Walking daily; gym work for the legs; no heavy lifting with the left arm for another two weeks |

## Goal progress

- Tissue diagnosis within one week of presentation. Outcome by 2026-10-05: Imaging and core biopsy the day after presentation; diagnosis explained on the sixth day. **S**
- Curative surgery within two weeks of diagnosis, with lymphedema prevention taught. Outcome by 2026-10-20: Mastectomy and axillary dissection two days after the diagnosis; clear margins; arm exercises and risk reduction taught. **S**
- Complete germline genetic testing with counseling before chemotherapy starts. In progress; target 2026-10-27. **S**
- Be ready to start adjuvant chemotherapy within six weeks of surgery: echocardiogram, hepatitis B screening, vaccines, and dental review done. In progress; target 2026-10-27. **S**

## Guideline basis

- Hassett MJ, et al. Management of Male Breast Cancer: ASCO Guideline. J Clin Oncol 2020;38(16):1849-1863 (2020), American Society of Clinical Oncology
- NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 5.2025 (2025), National Comprehensive Cancer Network
- Armenian SH, et al. Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: ASCO Clinical Practice Guideline. J Clin Oncol 2017;35(8):893-911 (2017), American Society of Clinical Oncology
- Hwang JP, et al. Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update. J Clin Oncol 2020 (2020), American Society of Clinical Oncology
- CMID: Clinical Monitoring Intelligence Database, breast cancer monograph (2026), Aether Forge

## Follow-up

- Echocardiogram this week. Preventive visit next week. Chemotherapy in about two weeks with medical oncology. Primary care review during chemotherapy. **S**
- Next scheduled visit 2026-10-27: periodic adult preventive visit before chemotherapy. **S**
